Pfizer Revenue Quarterly YoY Growth:
-12.37% for Dec. 31, 2012Pfizer Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -12.37% |
| Dec. 31, 2012 | -6.65% |
| Sept. 30, 2012 | -15.85% |
| June 30, 2012 | -8.66% |
| March 31, 2012 | -6.65% |
| Dec. 31, 2011 | 4.39% |
| Sept. 30, 2011 | 3.84% |
| June 30, 2011 | -3.78% |
| March 31, 2011 | -0.45% |
| Dec. 31, 2010 | -6.50% |
| Sept. 30, 2010 | 37.64% |
| June 30, 2010 | 55.97% |
| March 31, 2010 | 52.54% |
| Dec. 31, 2009 | 33.95% |
| Sept. 30, 2009 | -2.94% |
| June 30, 2009 | -9.44% |
| March 31, 2009 | -8.28% |
| Dec. 31, 2008 | -4.07% |
| Sept. 30, 2008 | -0.14% |
| June 30, 2008 | 9.43% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
PFE Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Johnson & Johnson | 8.46% |
| Merck | -9.04% |
| Bristol-Myers Squibb | -27.04% |
PFE Revenue Quarterly YoY Growth Rankings
| Overall |
48th percentile 4090 of 8007 |
| Sector |
40th percentile 411 of 685 in Healthcare |
| Industry |
53rd percentile 25 of 54 in Drug Manufacturers - Major |
PFE Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -15.85% | Sep 2012 |
| Maximum | 55.97% | Jun 2010 |
| Average | 5.60% |
